There were 1,626 press releases posted in the last 24 hours and 359,021 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image